trans-Resveratrol downregulates Txnip overexpression occurring during liver ischemia-reperfusion.

[1]  D. Wendum,et al.  Protective effect of post-ischemic treatment with trans-resveratrol on cytokine production and neutrophil recruitment by rat liver. , 2010, Biochimie.

[2]  G. Fontés,et al.  Lack of TXNIP Protects Against Mitochondria-Mediated Apoptosis but Not Against Fatty Acid–Induced ER Stress–Mediated β-Cell Death , 2009, Diabetes.

[3]  H. E. Marshall,et al.  Thioredoxin-interacting Protein (Txnip) Is a Feedback Regulator of S-Nitrosylation , 2009, The Journal of Biological Chemistry.

[4]  Richard T. Lee,et al.  Thioredoxin-independent Regulation of Metabolism by the α-Arrestin Proteins* , 2009, The Journal of Biological Chemistry.

[5]  D. Das,et al.  Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending on dose. , 2009, The Journal of nutritional biochemistry.

[6]  J. Coselli,et al.  Up-regulation of thioredoxin interacting protein (Txnip) by p38 MAPK and FOXO1 contributes to the impaired thioredoxin activity and increased ROS in glucose-treated endothelial cells. , 2009, Biochemical and biophysical research communications.

[7]  A. Shalev,et al.  Diabetes induces and calcium channel blockers prevent cardiac expression of proapoptotic thioredoxin-interacting protein. , 2009, American journal of physiology. Endocrinology and metabolism.

[8]  L. Billiet,et al.  Thioredoxin-1 is a novel and attractive therapeutic approach for various diseases including cardiovascular disorders. , 2008, Cardiovascular & hematological disorders drug targets.

[9]  H. Masutani,et al.  Thioredoxin and thioredoxin binding protein 2 in the liver , 2008, IUBMB life.

[10]  A. Shalev.  Lack of TXNIP protects beta-cells against glucotoxicity. , 2008, Biochemical Society transactions.

[11]  D. Wendum,et al.  Postischemic treatment by trans‐resveratrol in rat liver ischemia‐reperfusion: A possible strategy in liver surgery , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[12]  A. Lusis,et al.  Thioredoxin-Interacting Protein , 2008, Diabetes.

[13]  V. Pérez-Alvarez,et al.  Resveratrol and trimethylated resveratrol protect from acute liver damage induced by CCl4 in the rat , 2008, Journal of applied toxicology : JAT.

[14]  Richard T. Lee,et al.  Thioredoxin-interacting Protein (Txnip) Is a Critical Regulator of Hepatic Glucose Production* , 2008, Journal of Biological Chemistry.

[15]  J. Chung,et al.  Diverse functions of VDUP1 in cell proliferation, differentiation, and diseases. , 2007, Cellular & molecular immunology.

[16]  H. Masutani,et al.  Thioredoxin and thioredoxin-binding protein-2 in cancer and metabolic syndrome. , 2007, Free radical biology & medicine.

[17]  Richard T. Lee,et al.  Nitric Oxide–Dependent Suppression of Thioredoxin-Interacting Protein Expression Enhances Thioredoxin Activity , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[18]  M. Kampa,et al.  Resveratrol exerts its antiproliferative effect on HepG2 hepatocellular carcinoma cells, by inducing cell cycle arrest, and NOS activation. , 2006, Biochimica et biophysica acta.

[19]  D. Kotyzová,et al.  Comparative study of natural antioxidants - curcumin, resveratrol and melatonin - in cadmium-induced oxidative damage in mice. , 2006, Toxicology.

[20]  H. Jaeschke.  Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[21]  Joseph A. Baur,et al.  Therapeutic potential of resveratrol: the in vivo evidence , 2006, Nature Reviews Drug Discovery.

[22]  H. Masutani,et al.  Thioredoxin‐binding protein‐2 (TBP‐2): Its potential roles in the aging process , 2006, BioFactors.

[23]  J. Tillement,et al.  Resveratrol protects against cold ischemia-warm reoxygenation-induced damages to mitochondria and cells in rat liver. , 2005, European journal of pharmacology.

[24]  M. Knipp,et al.  A colorimetric 96-well microtiter plate assay for the determination of enzymatically formed citrulline. , 2000, Analytical biochemistry.

[25]  S. Homma,et al.  Acute Elevations of Plasma Asymmetric Dimethylarginine and Impaired Endothelial Function in Response to a High-Fat Meal in Patients With Type 2 Diabetes , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[26]  M. Vaubourdolle,et al.  Hepatoprotective effect of endogenous nitric oxide during ischemia‐reperfusion in the rat , 1999, Hepatology.

[27]  Elias S. J. Arnér,et al.  Preparation and assay of mammalian thioredoxin and thioredoxin reductase. , 1999, Methods in enzymology.

[28]  S. Tannenbaum,et al.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. , 1982, Analytical biochemistry.